A detailed history of Larson Financial Group LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Larson Financial Group LLC holds 165 shares of ELAN stock, worth $3,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165
Previous 84 96.43%
Holding current value
$3,479
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$13.68 - $20.14 $1,108 - $1,631
81 Added 96.43%
165 $3,000
Q2 2025

Aug 08, 2025

SELL
$8.1 - $14.3 $1,466 - $2,588
-181 Reduced 68.3%
84 $1,000
Q1 2025

May 02, 2025

BUY
$10.04 - $12.47 $1,244 - $1,546
124 Added 87.94%
265 $2,000
Q4 2024

Feb 07, 2025

BUY
$11.63 - $14.67 $1,639 - $2,068
141 New
141 $1,000
Q1 2022

May 05, 2022

SELL
$24.65 - $29.0 $2,045 - $2,407
-83 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$27.74 - $34.09 $2,302 - $2,829
83 New
83 $2,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $10B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.